Stockholders approve 4.75M share increase to equity plan and new ESPP at annual meeting

Niagen Bioscience, Inc.

Amendment to 2017 Equity Incentive Plan adds 4,750,000 shares; approved by 53,046,229 votes for.
Employee Stock Purchase Plan approved: 650,000 shares authorized, purchased at 85% of lower of grant/ purchase price.
All eight director nominees elected; Steven Rubin received 12.4M withheld votes, others largely unanimous.
Crowe LLP ratified as independent auditor for FY2025 with 63.4M votes for.
Advisory say-on-pay proposal passed with 54.9M for vs 1.2M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.